1.         Shen D, Lin J, Xie Y, Zhuang Z, Xu G, Peng S, Tang G, Bai L, Zhu M, Zhang Y, Huang Z, Wang P, Liu X, Huang M, Luo Y, Wang X, Yu H. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Clin Transl Med. 2023, 13(5):e1279.  (Co-corresponding author; IF=10.6)

2.         Liu X, Peng S, Tang G, Xu G, Xie Y, Shen D, Zhu M, Huang Y, Wang X, Yu H, Huang M, Luo Y. Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells. EBioMedicine. 2023, 90:104496. (Co-corresponding author; IF=11.1)

3.         Xie Y, Lin J, Zhang N, Wang X, Wang P, Peng S, Li J, Wu Y, Wu Y, Zhuang Z, Shen D, Zhu M, Liu X, Liu G, Meng X, Huang M, Yu H, Luo Y. Prevalent Pseudoprogression and Pseudoresidue in Rectal Cancer Patients Treated with Neoadjuvant Immune Checkpoint Inhibitors. J Natl Compr Canc Netw. 2023, 21(2):133-142. (Co-corresponding author; IF=13.4)

4.         Zhu M, Bai L, Liu X, Peng S, Xie Y, Bai H, Yu H, Wang X, Yuan P, Ma R, Lin J, Wu L, Huang M, Li Y, Luo Y, Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages. J Immunother Cancer. 2022, 10(12):e005610. (Co-corresponding author; IF=10.9)

5.         Yu H, Wang X, Bai L, Tang G, Carter KT, Cui J, Huang P, Liang L, Ding Y, Cai M, Huang M, Liu H, Cao G, Gallinger S, Pai RK, Buchanan DD, Win AK, Newcomb PA, Wang J, Grady WM, Luo Y. DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer. J Natl Cancer Inst. 2023, 115(1):52-61. (Co-corresponding author; IF=10.3)

6.         Peng S, Li Y, Huang M, Tang G, Xie Y, Chen D, Hu Y, Yu T, Cai J, Yuan Z, Wang H, Wang H, Luo Y, Liu X. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022;18(5):1912-1932. (Co-corresponding author; IF=9.2)

7.         Zou Q, Wang X, Ren D, Hu B, Tang G, Zhang Y, Huang M, Pai RK, Buchanan DD, Win AK, Newcomb PA, Grady WM, Yu H, Luo Y. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer, J ImmunoTher Cancer. 2021;9:e002671. (Co-corresponding author; IF=10.9)

8.         Zhuang Z, Liu Z, Li J, Wang X, Xie P, Xiong F, Hu J, Meng X, Huang M, Deng Y, Lan P, Yu H, Luo Y. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer, J Transl Med. 2021; 19(1): 256. (Co-corresponding author; IF=7.4)

9.         Xie Y, Lin J, Wang X, Wang P, Zhuang Z, Zou Q, Cai D, Huang Z, Bai L, Tang G, Huang M, Wang J, Yu H, Luo Y. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients with Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial, Dis Colon Rectum. 2021;64(11):1321-1330. (Co-corresponding author; IF=3.9)

10.     Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf). 2021;9(2):91-104.(IF=3.6)

11.     Zhuang Z, Wang X, Huang M, Luo Y, Yu H. Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer. J Gastrointest Oncol. 2021;12(2):568-579. (Co-corresponding author; IF=2.1）

12.     Zou Q, Ren D, Wang X, Bai L, Tang G, Huang M, Luo Y, Yu H. Improved Survival Outcome and Access to Cancer Screening from Hemorrhoid in Patients with Rectal Cancer, Gastroenterol Res Pract. 2020;2020:5045142. (Co-corresponding author; IF=2）

13.     Li Y, Bai L, Yu H, Cai D, Wang X, Huang B, Peng S, Huang M, Cao G, Kaz AM, Grady WM, Wang J, Luo Y. Epigenetic inactivation of α-internexin accelerates microtubule polymerization in colorectal cancer, Cancer Res. 2020;80(23):5203-5215. (IF=11.2)

14.     Luo Y, Wang P, Gu X, Ye J, Lin J, Tan M, Luo PT, Luo JT, Huang M. Three-trocar tubeless natural orifice specimen extraction surgery in rectosigmoid cancer – a video vignette. Colorectal Dis. 2020;22(10):0. (IF=3.4)

15.     Luo Y, Wang P, Liang J, Ye J, Tan M, Luo PT, Luo JT, Huang M. Tubeless NOSES in Rectosigmoid Cancers-Video Vignette. Colorectal Dis. 2020;22(1):105-106. (IF=3.4)

16.     Yu Z, Yu H, Zou Q, Huang Z, Wang X, Tang G, Bai L, Zhou C, Zhuang Z, Xie Y, Wang H, Xu G, Chen Z, Fu X, Huang M, Luo Y. Nomograms for prediction of molecular phenotypes in colorectal cancer. Onco Targets Ther. 2019, 13: 309-321. (IF=4)

17.     Huang P, Peng S, Yu H, Huang L, Yao Q, Wang X, Tan S, Zhou J, Wang P, Huang A, Bai L, Luo Y, Huang M, Decreased expression of SorCS1 in colorectal cancer: An independent predictor of poor prognosis, Neoplasma, 2020; 67(1): 119-128. (Co-corresponding author; IF=3）

18.     Cai D, Huang Z, Yu H, Wang X, Bai L, Tang G, Peng S, Li Y, Huang M, Cao G, Wang J, Luo Y. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer. World J Gastroenterol. 2019 25(33): 4945-4958. (IF=4.3)

19.     Luo Y, Wang P, Liang J, Ye J, Tan M, Luo PT, Luo JT, Huang M. Tubeless natural orifice specimen extraction surgery in rectosigmoid cancer - a video vignette. Colorectal Dis. 2020 Jan;22(1):105-106. (IF=3.4)

20.     Yu H, Bai L, Tang G, Wang X, Huang M, Cao G, Wang J, Luo Y. Novel Assay for Quantitative Analysis of DNA Methylation at Single-Base Resolution. Clin Chem. 2019, 65(5):664-673. (IF=9.3)

21.     Li L, Yu H, Liang J, Guo Y, Peng S, Luo Y, Wang J. Meta-analysis of the effectiveness of laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy for obesity. Medicine (Baltimore). 2019; 98(9): e14735.（Co-corresponding author; IF=1.6）

22.     Ren D, Li J, Yu H, Peng S, Lin W, Wang X, Ghoorun RA, Luo Y. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol. 2019, 25(1):118-137. (IF=4.3)

23.     Yu H, Luo Y. Decentered Crowdfunded Clinical Studies-Open a New Era of Medical Research. JAMA Oncol. 2019, 5(1):9-10. (IF=28.4)

24.     Li L, Wang X, Bai L, Yu H, Huang Z, Huang A, Luo Y, Wang J. The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats. J Diabetes Res. 2018: 1082561. (Co-corresponding author; IF=4.3)

25.     Yu H, Luo Y, Wang X, Bai L, Huang P, Wang L, Huang M, Deng Y, Wang J. Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer. Sci Rep. 2016;6:34131. (Co-corresponding author; IF=4.6)

26.     Yu H, Luo Y, Peng H, Wang X, Yang Z, Huang M, Kang L, Wang L, Wang J. Association of perioperative blood pressure with long-term survival in rectal cancer patients. Chin J Cancer. 2016;35:38. (Co-corresponding author; IF=5.1)

27.     Bosch LJ, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG, Koopman M, Nagtegaal ID, Punt CJ, van Criekinge W, Meijer GA, Monnat RJ, Jr., Carvalho B, Grady WM. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. Clin Cancer Res. 2016;22(18):4612-22. (Co-first author; IF=11.5)

28.     Huang A, Huang P, Luo Y, Wang B, Luo X, Zheng Z, Yuan K, Huang Z, Peng S, Yu H, Huang M, Cui J. CD103 expression in normal epithelium is associated with poor prognosis of colorectal cancer patients within defined subgroups. Int J Clin Exp Patho. 2017, 10(6):6624-6634.  (Co-first author; IF=1.4)

29.     Luo Y, Yu M, Grady WM. Field cancerization in the colon: a role for aberrant DNA methylation? Gastroenterol Rep (Oxf). 2014;2(1):16-20. (IF=3.6)

30.     Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014;147(2):418-29 e8. (IF=29.4)

31.     Luo Y, Wang L, Wang J. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: Opportunities and challenges. Proteomics Clin Appl. 2013;7(1-2):30-41. (IF=2)

32.     Luo Y, Kaz AM, Kanngurn S, Welsch P, Morris SM, Wang J, Lutterbaugh JD, Markowitz SD, Grady WM. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet. 2013;9(7):e1003552. (IF=4.5)

33.     Luo Y, Tsuchiya KD, Il Park D, Fausel R, Kanngurn S, Welcsh P, Dzieciatkowski S, Wang J, Grady WM. RET is a potential tumor suppressor gene in colorectal cancer. Oncogene. 2013;32(16):2037-47. (IF=8)

34.     Luo Y, Chen D, Song S, Wang L, Wang J. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta-analysis. Int J Clin Pract. 2011;65(12):1313-20. (IF=2.6)

35.     Luo Y, Wang L, Chen C, Chen D, Huang M, Huang Y, Peng J, Lan P, Cui J, Cai S, Wang J.Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Gastrointest Surg. 2010;14(12):1974-80. (IF=3.2)

36.     Luo Y, Cui J, Wang L, Chen D, Peng J, Lan P, Huang M, Huang Y, Cai S, Hu K, Li M, Wang J. Identification of cancer-associated proteins by proteomics and downregulation of beta-tropomyosin expression in colorectal adenoma and cancer. Proteomics Clin Appl. 2009;3(12):1397-406. (IF=2.0)